Bone Biologics Corporation (NAS: BBLGW) Stock Analysis & Fundamentals | ScreenerHero

Create free account

BBLGWBone Biologics Corporation

NAS · US · Basic Materials · Chemicals · bonebiologics.com

14.50USD0.00%Mkt Cap: —P/E: —2d ago

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromoti…

Industry Peers

Chemicals

vs Chemicals

P/B

Pricier

1M Perf

Lower

$44.97BUSDP/E 27.5

Celanese Corporation

Dottikon ES Holding AG

$4.35BUSDP/E 36.9

Methanex Corporation

$2.58BUSDP/E 15.1

Olin Corporation

$1.84BUSDP/E 17.0

Huntsman Corporation

$1.68BUSDP/E 12.4

$1.52BUSDP/E 14.2

REX American Resources Corporation

$1.49BUSDP/E 16.1

Chemtrade Logistics Income Fund

$1.27BUSDP/E 15.2

Green Plains Inc.

Petkim Petrokimya Holding Anonim Sirketi

Tronox Holdings plc

Westlake Chemical Partners LP

$784.57MUSDP/E 13.6

ASP Isotopes Inc.

LSB Industries, Inc.

$777.66MUSDP/E 17.2

$535.95MUSDP/E 55.2

Rayonier Advanced Materials Inc.

Chimcomplex S.A.

$327.85MUSDP/E 23.8

Ascent Industries Co.

$93.72MUSDP/E 23.0

IBU-tec advanced materials AG

$83.90MUSDP/E Infinity

Elton International Trading Company S.A.

$53.75MUSDP/E 14.2

Aciselsan Acipayam Selüloz Sanayi ve Ticaret A.S.

$35.64MUSDP/E 0.0

Sodas Sodyum Sanayii A.S.

Origin Materials, Inc.

Alpha Modus Holdings, Inc.

Navient Corporation SR NT 6% 121543

Indicators:|

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-3.11M $

Revenue/Share—

Last Price14.50 USD

Fiscal Year End—

MR Quarter—

Employees2

CountryUS

SectorBasic Materials

IndustryChemicals

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B5.00

EPS (TTM)-0.14

EPS (Forward)—

52W Range

8.30022% of range35.95

52W High35.95 USD

52W Low8.300 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-57.81%

ROA-53.64%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.69M $

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt-4.53M $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio16.09

Quick Ratio14.67

Book Value/Sh2.601 USD

Cash/Share2.523 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float1.79M

Insiders—

Institutions—

Technical

SMA 5017.28 (-16.1%)

SMA 20017.82 (-18.6%)

Beta0.56

S&P 52W Chg20.05%

Avg Vol (30d)294

Avg Vol (10d)410

Technical Indicators

RSI (14)43.0

MACD-0.9944

MACD Signal-1.1409

MACD Hist.+0.1464

BB Upper18.25 USD

BB Middle15.10 USD

BB Lower11.95 USD

BB Width41.69%

ATR (14)0.8350 USD

Vol Ratio (20d)0.00x